Literature DB >> 33587282

Quality of life and patient-reported outcomes in chronic severe neutropenia conditions.

Thomas F Michniacki1, Lauren E Merz2, Harlan McCaffery3, James A Connelly4, Kelly Walkovich5.   

Abstract

Quality of life (QOL) and patient-reported outcomes (PROs) assessments in immunodeficiency patients, including those with chronic severe neutropenia conditions, are imperative to determining modifiable health-related features to optimize care. We present the largest study to date of QOL in those with chronic severe neutropenia conditions with further evaluation of patient provider satisfaction and patient-reported outcome measures. Subjects completed electronic surveys assessing QOL, PROs, and patient provider satisfaction. There is a significantly negative impact of a chronic severe neutropenia disorder on QOL, fatigue, physical function, cognitive function and pain in adult patients when compared to controls. Children with a chronic neutropenia condition had comparable QOL to controls, but reported fewer depressive symptoms, improved mobility, and stronger self-reported peer relationships. Adults had worse scores for QOL, depression and fatigue when compared to children. Adult and pediatric chronic severe neutropenia patients or their caregivers felt that their medical provider was compassionate, trustworthy, and accessible. However, less than 50% of adult patients agreed their clinician had excellent expertise in white blood cell disorders. Chronic neutropenia complexly affect QOL and PROs. An analysis of these parameters allows for targeted interventions to improve patient psychosocial, physical and neurocognitive health.

Entities:  

Keywords:  Granulocyte colony-stimulating factor; Medical provider satisfaction; Neutropenia; Patient reported outcomes; Quality of life

Year:  2021        PMID: 33587282     DOI: 10.1007/s12185-021-03089-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  1 in total

1.  The impact of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia.

Authors:  M T Fazio; J A Glaspy
Journal:  Oncol Nurs Forum       Date:  1991 Nov-Dec       Impact factor: 2.172

  1 in total
  1 in total

1.  Outcomes for patients with severe chronic neutropenia treated with granulocyte colony-stimulating factor.

Authors:  David C Dale; Audrey Anna Bolyard; James A Shannon; James A Connelly; Daniel C Link; Mary Ann Bonilla; Peter E Newburger
Journal:  Blood Adv       Date:  2022-07-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.